Navigation Links
IRIDEX Announces Shipment of New IQ 577(TM) Laser Systems
Date:4/30/2009

New Technology Represents First True Yellow Laser with CW-Pulse(TM) and MicroPulse(TM) Delivery

MOUNTAIN VIEW, Calif., April 30 /PRNewswire-FirstCall/ -- IRIDEX Corporation, (Nasdaq: IRIX) today announced the commencement of shipments to customers of the IQ 577 laser systems. The IQ 577 is a high-power, true yellow (577 nm wavelength) laser system for use by ophthalmologists to treat sight-threatening eye diseases such as diabetic retinopathy, age-related macular degeneration and glaucoma.

The IQ 577 offers tangible benefits to both patient and physician. Patients benefit from less discomfort. The higher inherent absorption in blood, together with the lower scattering of the 577 nm yellow laser wavelength, compared with 532 nm green laser systems, helps to reduce the therapeutic power requirements and resultant patient discomfort. Physicians benefit from efficiencies due to its easy to understand user interface, wireless foot pedal control with power adjust capability, and audible confirmation of adjustments.

"The 577 nm laser wavelength previously was available to ophthalmologists only in argon-pumped dye laser systems," commented Theodore A. Boutacoff, President and CEO. "These argon-pumped dye laser systems, now obsolete, were popular at one time; however, they were large, had high electrical power demands, required circulating water for cooling, and were expensive to maintain and service. In contrast, we have directed our company's experience and expertise to develop the IQ 577, reintroducing this laser wavelength to clinicians in a modern product utilizing reliable and efficient solid-state laser technology. The integration of MicroPulse technology into the IQ 577 ensures that it will satisfy not only today's clinical requirements, but also those of the future. Also in contrast to the previous dye laser systems, the IQ 577 visualization optics are substantially clearer and provides the ophthalmic laser surgeon with the ability to visually titrate subtle laser doses, which enhances preservation of viable tissue."

What is MicroPulse Technology?

MicroPulse is a tissue sparing technology offering a benefit over standard laser delivery by electronically "chopping" each laser pulse into microsecond bursts. This enhances the physician's control over the energy delivered to tissue, opening the door to new ocular treatment options, with the goal, once again, of achieving a more tissue sparing laser therapy.

About IRIDEX

IRIDEX Corporation is a leading worldwide provider of therapeutic based laser systems, disposable laser probes and delivery devices to treat eye diseases in ophthalmology and skin disorders in the aesthetics market. IRIDEX products are sold in the United States through a direct sales force and internationally through a combination of a direct sales force and a network of approximately 100 independent distributors into 107 countries. For further information, visit the Company's website at http://www.iridex.com.


'/>"/>
SOURCE IRIDEX Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IRIDEX Reports Fourth Quarter and Full Year 2008 Financial Results
2. IRIDEX Announces Fourth Quarter and Full Year 2008 Conference Call and Release Date
3. IRIDEX Reports Third Quarter 2008 Financial Results
4. IRIDEX Announces Third Quarter 2008 Conference Call and Release Date
5. IRIDEX Reports First Quarter 2008 Financial Results
6. IRIDEX Announces First Quarter 2008 Conference Call and Release Date
7. IRIDEX Reports Fourth Quarter and Full Year 2007 Financial Results
8. IRIDEX Announces Fourth Quarter and Full Year 2007 Conference Call and Release Date
9. IRIDEX Reports Third Quarter Financial Results
10. IRIDEX Announces Third Quarter 2007 Conference Call and Release Date
11. Theodore A. Boutacoff Appointed President & CEO of IRIDEX
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... Lewisville, TX (PRWEB) , ... June 25, 2016 , ... ... in the United States, named Dr. Sesan Ogunleye, as the Medical Director of its ... be the facility Medical Director of our new Mesquite location,” said Dr. James M. ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her son ... lash out at his family verbally and physically. , “When something upset him, he couldn’t ... would use it. He would throw rocks at my other children and say he was ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... Research and Markets has announced the addition ... Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, Binder, ... Forecast to 2021" report to their offering. ... excipients market is projected to reach USD 8.1 Billion ... forecast period 2016 to 2021. The ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology: